Travere Therapeutics Inc (TVTX)
Operating Expenses
$598.71M
TTM · Period ending: · USD
TVTX Operating Expenses
Latest reported$598.71Mperiod ending
Latest reported$598.71Mperiod ending
TVTX Operating Expenses ($13.43K → $598.71M)
Annual operating expenses
High-resolution chart · PNG
TVTX operating expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 543,213,000 | |
| 549,258,000 | |
| 521,926,000 | |
| 424,853,000 | |
| 327,443,000 | |
| 368,358,000 | |
| 269,914,000 | |
| 227,411,000 | |
| 182,126,000 | |
| 168,868,000 | |
| 129,967,000 | |
| 107,439,919 | |
| 23,972,073 | |
| 30,257,017 | |
| 12,825 | |
| 13,432 |